Sunday, 16 August 2026

Indian corporate news, decoded into deal flow

NSE LIVE
NIFTY 50 INDIA VIX
as of
MARKETS
DEAL FLOW
Mahindra BE 6 SPORTEQ Launched: Price… ▲ Product & Services PM Modi Independence Day Speech: Defence,… ▲ Market News / Economy Stocks to Watch on Monday, August… ▲ Market News / Economy Remsons Industries Q1 FY27 Investor Presentation:… ▲ Results Godrej Consumer Products: New CEO Aasif… ▲ Results NMDC Steel Q1 FY27 Results: Revenue… ▲ Results UPL to Acquire Egyptian Seed Company… ▲ Mergers & Acquisitions
Home / Capex & Future Plans / Epigral Limited’s Expansion Plans
CX · Capex & Future Plans

Epigral Limited’s Expansion Plans

Epigral Limited (formerly Meghmani Finechem Limited) has announced plans to expand production capacity for Chlorinated Polyvinyl Chloride (CPVC) Resin and Epichlorohydrin at its Dahej facility in Gujarat. This expansion, approved by the Board of Directors on November 9, 2024, aims to leverage market growth opportunities and boost the company’s market share.

Expansion Details:

  • CPVC Resin:

    • Current capacity: 75,000 TPA (tonnes per annum)
    • Current utilization: 65%
    • Planned capacity addition: 75,000 TPA
    • Total capacity post-expansion: 150,000 TPA
  • Epichlorohydrin:

    • Current capacity: 50,000 TPA
    • Current utilization: 80%
    • Planned capacity addition: 50,000 TPA
    • Total capacity post-expansion: 100,000 TPA

Completion of the expansion is targeted for the first half of the 2027 fiscal year (H1 FY2027). The project requires an estimated investment of Rs. 780 crore, which will be financed through a mix of internal accruals and debt.